MCI Clinical Trials

107 recruitingLast updated: June 18, 2026

There are 107 actively recruiting mci clinical trials across 31 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1, Phase 4. Top locations include Toronto, Ontario, Canada, Phoenix, Arizona, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


MCI Trials at a Glance

107 actively recruiting trials for mci are listed on ClinicalTrialsFinder across 6 cities in 31 countries. The largest study group is Not Applicable with 59 trials, with the heaviest enrollment activity in Toronto, Phoenix, and Boston. Lead sponsors running mci studies include St. Joseph's Hospital and Medical Center, Phoenix, University of California, San Francisco, and Centre for Addiction and Mental Health.

Treatments under study

About MCI Clinical Trials

Looking for clinical trials for MCI? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new MCI trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about MCI clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 107 trials

Recruiting
Phase 2

Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone

Sleep DisturbanceAMCI - Amnestic Mild Cognitive Impairment
Johns Hopkins University100 enrolled1 locationNCT05282550
Recruiting
Not Applicable

e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most

DementiaMild Cognitive Impairment (MCI)Potentially Inappropriate Medication Use
Johns Hopkins University100 enrolled1 locationNCT07454824
Recruiting
Not Applicable

Pre-incisional Infiltration With Ropivacaine Plus Triamcinolone for Relieving Postoperative Pain After Thoracoscopic Surgery

Video-assisted Thoracoscopic Surgery (VATS)SegmentectomyWedge Resection+3 more
Beijing Tiantan Hospital100 enrolled1 locationNCT07603921
Recruiting
Not Applicable

rTMS Combined With Aerobic Exercise for Older Adults With Mild Cognitive Impairment and Comorbid Depression

Depressive SymptomsMild Cognitive Impairment (MCI)
Cheng-Hsin General Hospital45 enrolled1 locationNCT07652775
Recruiting
Not Applicable

Using Light Therapy for Mild Cognitive Impairment

Mild Cognitive Impairment (MCI)Amyloid Pathology
University of Oklahoma40 enrolled1 locationNCT07651787
Recruiting
Phase 3

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

Urinary Bladder NeoplasmsImmune Checkpoint InhibitorsMethotrexate+4 more
AstraZeneca150 enrolled59 locationsNCT06960577
Recruiting
Not Applicable

The Cognitive Protective Effect of VR-based Cognitive Training in Type 2 Diabetes Patients With Mild Cognitive Impairment

Type 2 Diabetes Mellitus (T2DM)Mild Cognitive Impairment (MCI)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School40 enrolled1 locationNCT07650318
Recruiting
Not Applicable

Temporal Interference Stimulation Treatment in Patients With Cognitive Impairment

FTDAD - Alzheimer's DiseaseAD-MCI+1 more
Tianjin Huanhu Hospital60 enrolled1 locationNCT07643363
Recruiting

InRAD Observational Study

Mild Cognitive Impairment (MCI)Alzheimer's Disease(AD)Subjective Cognitive Decline (SCD)+1 more
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation50,000 enrolled2 locationsNCT07213700
Recruiting
Phase 2

Biomarker-based Trial of NPC-1 for Alzheimer's Pathology

Alzheimer DiseaseMild Cognitive Impairment (MCI)Subjective Cognitive Decline (SCD)
Massachusetts General Hospital40 enrolled1 locationNCT07236190
Recruiting

Dementia With Lewy Bodies: Clinical Symptoms, Biomarkers and Progression

Mild Cognitive Impairment (MCI)Other DementiasCognitively Unimpaired+1 more
Karolinska Institutet600 enrolled1 locationNCT07629349
Recruiting

Assessment of Motor Reserve in the Preclinical Stages of Dementia

Mild Cognitive Impairment (MCI)
Istituto per la Ricerca e l'Innovazione Biomedica200 enrolled1 locationNCT07634055
Recruiting

Crownlands Observing Progression With Neurons Study

Mild Cognitive Impairment (MCI)Alzheimer s Disease
Crownlands160 enrolled1 locationNCT07611396
Recruiting
Not Applicable

Telehealth-Adapted Compensatory Training and Intervention for Cognition

Mild Cognitive Impairment (MCI)Mild Cognitive ImpairmentMCI
University of Florida100 enrolled1 locationNCT07366346
Recruiting
Phase 1

Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients

Mild Cognitive Impairment (MCI)
Pravat Mandal9 enrolled1 locationNCT07583251
Recruiting
Phase 2

Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.

Mild Cognitive ImpairmentEarly Alzheimer's DiseaseAD-MCI
Bernard (Barry) Baumel10 enrolled1 locationNCT07512362
Recruiting
Not Applicable

Brain Stimulation and Cognitive Training for MCI

Mild Neurocognitive DisorderCognitive DysfunctionMild Cognitive Impairment (MCI)+2 more
Medical University of South Carolina50 enrolled1 locationNCT07526740
Recruiting
Phase 2

Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease

Alzheimer s DiseaseMild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Weill Medical College of Cornell University20 enrolled1 locationNCT07553338
Recruiting
Phase 4

Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs

Alzheimer Dementia (AD)Alzheimer s DiseaseMCI-AD, Early Stage Alzheimer's Disease
First Affiliated Hospital of Wenzhou Medical University200 enrolled1 locationNCT07604896
Recruiting
Not Applicable

Mindfulness With Dual-Task Training in Post-Stroke Mild Cognitive Impairment

StrokeMild Cognitive Impairment (MCI)
Nanjing Mingzhou Rehabilitation Hospital60 enrolled1 locationNCT07603102